Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 77 entries
View as:

A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01965418 Org: User:
Start: 09/30/13 End: - Due: -

A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT05017714 Org: User:
Start: 08/31/21 End: 08/31/22 Due: 08/31/23

Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01220492 Org: User:
Start: 05/31/09 End: 04/30/16 Due: 04/30/17

TCR-Redirected T Cells Therapy in Patient With HBV Related HCC

Phase: N/A Priority: Normal
NCT ID: NCT03899415 Org: User:
Start: 04/20/19 End: 06/01/24 Due: 06/01/25

Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05402722 Org: User:
Start: 01/01/22 End: 06/30/23 Due: 06/30/24

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

Phase: N/A Priority: Normal
NCT ID: NCT06364800 Org: User:
Start: 04/26/24 End: 09/26/26 Due: 09/26/27

OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI

Phase: N/A Priority: Normal
NCT ID: NCT02415283 Org: User:
Start: 05/31/15 End: 12/31/16 Due: 12/31/17

Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance

Phase: N/A Priority: Normal
NCT ID: NCT01690247 Org: User:
Start: 02/29/12 End: 02/28/15 Due: 02/28/16

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT06926647 Org: User:
Start: 05/01/25 End: 12/31/28 Due: 12/31/29

Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT06392503 Org: User:
Start: 11/30/23 End: 12/31/25 Due: 12/31/26

Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC

Phase: N/A Priority: Normal
NCT ID: NCT06059885 Org: User:
Start: 12/22/21 End: 12/20/25 Due: 12/20/26

HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC

Phase: N/A Priority: Normal
NCT ID: NCT05834699 Org: User:
Start: 01/01/23 End: 04/30/25 Due: 04/30/26

Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT01666990 Org: User:
Start: 06/30/12 End: 12/31/16 Due: 12/31/17

Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT04518774 Org: User:
Start: 08/15/20 End: 08/15/21 Due: 08/15/22

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT02651376 Org: User:
Start: 09/30/15 End: 08/31/17 Due: 08/31/18

Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06236594 Org: User:
Start: 09/18/23 End: 12/31/24 Due: 12/31/25

The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion

Phase: N/A Priority: Normal
NCT ID: NCT01878565 Org: User:
Start: 06/30/13 End: 07/31/15 Due: 07/31/16

Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04251871 Org: User:
Start: 01/22/20 End: 01/22/21 Due: 01/22/22

Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

Phase: N/A Priority: Normal
NCT ID: NCT04565262 Org: User:
Start: 09/30/20 End: 09/30/23 Due: 09/30/24

Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT05057104 Org: User:
Start: 10/10/21 End: 12/31/24 Due: 12/31/25

Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

Phase: N/A Priority: Normal
NCT ID: NCT05227846 Org: User:
Start: 03/22/22 End: 03/01/25 Due: 03/01/26

Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01607021 Org: User:
Start: 04/30/12 End: 12/31/15 Due: 12/31/16

Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.

Phase: N/A Priority: Normal
NCT ID: NCT03091244 Org: User:
Start: 03/25/17 End: 12/31/17 Due: 12/31/18

RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure

Phase: N/A Priority: Normal
NCT ID: NCT02331745 Org: User:
Start: 10/31/13 End: 10/31/16 Due: 10/31/17

Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis

Phase: N/A Priority: Normal
NCT ID: NCT01661842 Org: User:
Start: 10/31/11 End: 10/31/14 Due: 10/31/15